While the new coronavirus infection has a major impact on the acceptance of cancer screening, we aim to reduce the burden on medical facilities and the anxiety of the general public as much as possible. We have decided to start a new N-NOSE reception service “Go To N-NOSE” by this fall. You can apply “Go To N-NOSE” directly from our website. As soon as we are ready, we will publish the details on this page and at https://xn--icktbzci4u.com/.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05